Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 05/06 10:24:06 am
23780 ILa   -0.50%
12:21p Alexion bolsters rare disease drugs business with $8.4 billion de..
07:16a TEVA PHARMACEUT : outlines positives of Mylan offer
05/05 AUSPEX PHARMACE : Teva completes $3.2b acquisition of Auspex
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on TEVA PHARMACEUTICAL INDUST
12:39p TEVA PHARMACEUTICAL : Trademark Application for "DURA MED" Filed by Teva Pharmac..
12:21p Alexion bolsters rare disease drugs business with $8.4 billion deal
07:16a TEVA PHARMACEUTICAL : outlines positives of Mylan offer
05/05 AUSPEX PHARMACEUTICALS : Teva completes $3.2b acquisition of Auspex
05/05 TEVA PHARMACEUTICAL : Completes Acquisition of Auspex Pharmaceuticals
05/05 TEVA PHARMACEUTICAL : Provides Additional Detail on Proposed Acquisition of Myla..
05/04 BENNY LANDA : Teva would be wrong to buy Mylan
05/03 TEVA PHARMACEUTICAL : What does Mylan really think it's worth?
05/01DJDrug Maker Mylan Sues Law Firm Kirkland & Ellis
05/01 TEVA PHARMACEUTICAL : still pursuing merger with Mylan
04/30 TEVA PHARMACEUTICAL : CEO to Mylan chairman: You distort the picture
04/30 TEVA PHARMACEUTICAL : raises 2015 guidance
04/30 EXCLUSIVE : Pfizer is mystery bidder for rare disease drugmaker Sobi - sources
04/30DJTeva Raises Guidance as Generic-Medicine Segment Grows
04/30DJTeva Raises Guidance as Generic-Medicine Segment Grows
04/30 TEVA PHARMACEUTICAL : Reports First Quarter 2015 Results
04/30 TEVA PHARMACEUTICAL : Committed to Cash-and-Stock Acquisition of Mylan
04/29 Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy
04/29 TEVA PHARMACEUTICAL : Sends Letter to Mylan Board
04/29 ACTIVE BIOTECH : Teva and Active Biotech Announce First Patient Enrolled in Phas..
04/29 TEVA PHARMACEUTICAL : Presents Data Comparing Early Treatment with COPAXONE® 40 ..
04/29 TEVA PHARMACEUTICAL : to Report First Quarter 2015 Financial Results on April 30..
04/29 PERRIGO : Mylan again boosts offer for drugmaker Perrigo
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion -- 2nd Update
04/29 Exclusive - Perrigo expected to reject Mylan's latest offer
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion--Update
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion
04/28 TAMIR FISHMAN VENTURE CAPITAL II : Capital soars after court ruling against Teva
04/28 TEVA PHARMACEUTICAL : Globes, Tel Aviv, Israel, Shiri Habib-Valdhorn column
04/28 PERRIGO : "Even at $100 per share Teva's Mylan bid worthwhile"
04/28 PERRIGO : "Mylan chairman is uncouth with an enormous ego"
04/28 TEVA PHARMACEUTICAL : Launches Generic Abilify® Tablets in the United States
04/28 TEVA PHARMACEUTICAL : Mylan spurns $40B deal
04/28 TEVA PHARMACEUTICAL : Continues to Invigorate Injectable Portfolio with the Laun..
04/28 TEVA PHARMACEUTICAL : Issues Data Comparing Early Treatment with COPAXONE 40 mg/..
04/28 TEVA PHARMACEUTICAL : and Active Biotech: Patient Enrolled in Phase II Study Eva..
04/28 TEVA PHARMACEUTICAL : reiterates commitment to Cash-and-Stock acquisition of Myl..
04/27 BIOMARIN PHARMACEUTICAL : CRY Has A Reason To Smile, MDXG Lifts Outlook, MYL Rej..
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update
04/27DJU.S. Stocks End Lower
04/27DJADR Shares End Mixed; Teva Declines
04/27 TEVA PHARMACEUTICAL : Mylan rejects Teva Pharmaceutical's takeover bid
04/27 PERRIGO : Mylan board unanimously rejects Teva bid
04/27 TEVA PHARMACEUTICAL : undeterred by Mylan rejection
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid--3rd Update
04/27 Mylan says Teva offer too low; criticizes stock, growth prospects
04/27 TEVA PHARMACEUTICAL : Mylan rejects Teva's $40 billion takeover bid
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid--2nd Update
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid -- Update
04/27 TEVA PHARMACEUTICAL : Reiterates Commitment to Cash-and-Stock Acquisition of Myl..
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid
04/27 PERRIGO : Mylan rejects Teva's $40.1 billion buyout offer
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid
04/24 ACTIVE BIOTECH : Teva and Active Biotech Announce First Patient Enrolled in Phas..
04/24DJMylan Raises Bid for Generic Drug Maker Perrigo -- 6th Update
04/24DJMylan Raises Bid for Generic Drug Maker Perrigo -- 5th Update
04/24DJMylan Raises Bid for Generic Drug Maker Perrigo -- 4th Update
04/24DJMylan to Make Formal Bid for Perrigo -- 3rd Update
04/24DJMylan to Make Formal Bid for Perrigo -- 2nd Update
04/24DJMylan to Make Formal Bid for Perrigo -- Update
04/24DJMylan Raises Bid for Generic Drug Maker Perrigo
04/24DJMylan to Make Formal Bid for Perrigo
04/23 TEVA PHARMACEUTICAL : and Active Biotech Announce First Patient Enrolled in Phas..
04/23 TEVA PHARMACEUTICAL : Presents Data Comparing Early Treatment with COPAXONE® 40 ..
04/23 TEVA PHARMACEUTICAL : Mylan pressured to accept $40B buyout bid by Teva
04/23 Active Biotech Interim report January - March 2015
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/22 EAGLE PHARMACEUTICALS : Teva and Eagle Pharmaceuticals Announce NDA for Bendamus..
04/22 Teva ready to divest operations to win regulatory nod for Mylan buy
04/22DJThe Rise of the 'Stichting,' an Obscure Takeover Defense
04/22DJThe Rise of the 'Stichting,' an Obscure Takeover Defense
04/22 Teva Pharmaceutical's history of key acquisitions
04/22 Teva's turnaround CEO sets sights on $40 billion mega-deal
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF